Advancements in Biomolecule or Cell-Based Nanosystems for Cancer Diagnosis and Treatment

Cancer consistently presents a pressing global health concern, necessitating innovative approaches for its early diagnosis and effective treatment. In recent years, biomolecule or cell-based nanosystems have emerged as promising tools for the precise detection of cancer, targeted drug delivery, and innovative therapeutics. These nanosystems offer the potential to revolutionize cancer care by providing more accurate diagnostic capabilities and enhancing the efficacy of treatments while minimizing side effects. Despite the promising advancements, challenges remain in optimizing these nanosystems for clinical application, including issues related to biocompatibility, targeted delivery, and scalability. Current studies have demonstrated the potential of these nanosystems in preclinical models, yet there is a significant gap in translating these findings into clinical practice. Addressing these challenges requires a multidisciplinary approach, integrating insights from nanotechnology, molecular biology, and oncology to refine and advance these nanosystems for practical use in cancer diagnosis and treatment.

This Research Topic aims to explore the latest advancements in nanosystems specifically designed for cancer diagnosis and therapeutic interventions. Our objective is to gather experts from diverse academic disciplines to share their research findings and insights regarding the burgeoning advancements in biomolecule or cell-based nanosystems applied in cancer treatments. We encourage contributions that shed light on various aspects, including the design, synthesis, characterization, and application of nanosystems in the scope of cancer diagnosis and therapy.

To gather further insights in the development and application of biomolecule or cell-based nanosystems for cancer diagnosis and treatment, we welcome articles addressing, but not limited to, the following themes:
- The development of novel strategies for biomolecule-based nanosystems applied in cancer imaging and diagnostics.
- The use of cell-based nanosystems for targeted drug delivery and controlled release in cancer therapy.
- Bioconjugation techniques employed for the functionalization of biomolecules within nanosystems, enhancing cancer-specific targeting.
- Hybrid nanosystems that integrate both biomolecules and nanoparticles, enabling multimodal cancer imaging and therapy.
- Biocompatibility and toxicity assessment of biomolecule or cell-based nanosystems for safe clinical translation.

Keywords: Biomolecule-based nanosystems, Cell-based nanosystems, Cancer diagnosis, Therapeutic interventions

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.